Intervention
Pemetrexed Disodium
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 23 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
23 shownPerioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung CancerNCT06659042 · 2024-11-20
RECRUITINGA Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumorsNCT06475300 · 2024-06-25
RECRUITINGTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])NCT04267848 · 2020-06-16
RECRUITINGPembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung CancerNCT04061590 · 2020-05-29
WITHDRAWNComparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)NCT04379635 · 2020-05-29
ACTIVE_NOT_RECRUITINGTesting the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung CancerNCT04092283 · 2020-04-29
ACTIVE_NOT_RECRUITINGTesting the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural MesotheliomaNCT04158141 · 2020-01-29
TERMINATEDRamucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)NCT03971474 · 2019-05-28
COMPLETEDAtezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant MesotheliomaNCT03228537 · 2018-07-16
ACTIVE_NOT_RECRUITINGNivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung CancerNCT03366766 · 2017-12-20
TERMINATEDMaintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerNCT03137771 · 2017-04-07
ACTIVE_NOT_RECRUITINGMethoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or CarboplatinNCT02535312 · 2016-03-08
ACTIVE_NOT_RECRUITINGFludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by SurgeryNCT02607423 · 2015-11-19
WITHDRAWNMethoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung CancerNCT02535325 · 2015-09-30
COMPLETEDPemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3NCT02426658 · 2015-05-01
COMPLETEDGenetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26
ACTIVE_NOT_RECRUITINGComparing Photon Therapy To Proton Therapy To Treat Patients With Lung CancerNCT01993810 · 2014-01-03
ACTIVE_NOT_RECRUITINGAzacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerNCT01935947 · 2013-05-01
TERMINATEDPemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural MesotheliomaNCT01064648 · 2010-03-15
ACTIVE_NOT_RECRUITINGPemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung CancerNCT00738881 · 2008-10-01
TERMINATEDPemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerNCT00698815 · 2008-04-15
COMPLETEDChemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryNCT00324805 · 2007-07-19
COMPLETEDPemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung CancerNCT00950365 · 2006-04-01
COMPLETEDCommon conditions
Recurrent Non-Small Cell Lung Carcinoma5Stage IV Non-Small Cell Lung Cancer5Stage IIIA Lung Cancer AJCC v84Stage IIIA Non-Small Cell Lung Cancer4Stage IIIA Lung Non-Small Cell Cancer AJCC v73Stage IIIB Lung Cancer AJCC v83Stage IIIB Non-Small Cell Lung Cancer3Epithelioid Mesothelioma2Lung Non-Small Cell Carcinoma2Recurrent Lung Non-Small Cell Carcinoma2Stage IB Lung Non-Small Cell Carcinoma AJCC v72Stage II Lung Cancer AJCC v82Stage IIA Lung Cancer AJCC v82Stage IIB Lung Cancer AJCC v82Stage IIIB Non-Small Cell Lung Cancer AJCC v72Advanced Malignant Solid Neoplasm1Advanced Peritoneal Malignant Mesothelioma1Advanced Pleural Malignant Mesothelioma1Biphasic Mesothelioma1Bronchioloalveolar Carcinoma1Large Cell Lung Carcinoma1Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma1Lung Adenocarcinoma1Lung Cancer, Non-Small Cell1Lung Non-Small Cell Squamous Carcinoma1
Leading sponsors
National Cancer Institute (NCI)11NRG Oncology2Albert Einstein College of Medicine1BeiGene1ECOG-ACRIN Cancer Research Group1Radiation Therapy Oncology Group1Shanghai Chest Hospital1Sichuan Baili Pharmaceutical Co., Ltd.1Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University1SWOG Cancer Research Network1University of California, San Francisco1Wake Forest University Health Sciences1
Trial status mix
ACTIVE_NOT_RECRUITING8
COMPLETED6
TERMINATED4
RECRUITING3
WITHDRAWN2
Phase mix
PHASE213
PHASE37
PHASE14
NA1
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.